These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3499211)

  • 21. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
    Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
    Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia.
    Stryckmans P; De Witte T; Bitar N; Marie JP; Suciu S; Solbu G; Debusscher L; Bury J; Peetermans M; Andrien JM
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):67-72. PubMed ID: 3296209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved survival in adult acute lymphoblastic leukemia. Need for more effective CNS prophylaxis.
    Stein RS; Baer MR; Flexner JM
    Am J Clin Oncol; 1985 Apr; 8(2):162-6. PubMed ID: 3869432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic combination chemotherapy for acute lymphoblastic leukemia recurring after elective cessation of therapy.
    Pui CH; Bowman WP; Ochs J; Dodge RK; Rivera GK
    Med Pediatr Oncol; 1988; 16(1):21-6. PubMed ID: 3422333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.
    Tower RL; Jones TL; Camitta BM; Asselin BL; Bell BA; Chauvenet A; Devidas M; Halperin EC; Pullen J; Shuster JJ; Winick N; Kurtzberg J
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):353-61. PubMed ID: 24608079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy of childhood acute lymphoblastic leukemia.
    Bell BA; Whitehead VM
    Dev Pharmacol Ther; 1986; 9(3):145-70. PubMed ID: 3519131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group.
    Brandalise S; Odone V; Pereira W; Andrea M; Zanichelli M; Aranega V
    Leukemia; 1993 Aug; 7 Suppl 2():S142-5. PubMed ID: 8361220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
    Rivera G; Dahl GV; Bowman WP; Avery TL; Wood A; Aur RJ
    Cancer; 1980 Oct; 46(8):1727-30. PubMed ID: 6932995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk groups in a multicenter pilot study for treatment of acute lymphoblastic and acute undifferentiated leukemia in adults.
    Hoelzer D; Thiel E; Löffler H; Bodenstein H; Büchner T; Engelhardt R; Ganser A; Messerer D; Rühl H; Zwingers T
    Haematol Blood Transfus; 1985; 29():48-50. PubMed ID: 3861487
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.
    Bleyer WA; Sather HN; Nickerson HJ; Coccia PF; Finklestein JZ; Miller DR; Littman PS; Lukens JN; Siegel SE; Hammond GD
    J Clin Oncol; 1991 Jun; 9(6):1012-21. PubMed ID: 2033414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
    Hinze L; Möricke A; Zimmermann M; Junk S; Cario G; Dagdan E; Kratz CP; Conter V; Schrappe M; Stanulla M
    Leukemia; 2017 Aug; 31(8):1840-1842. PubMed ID: 28529312
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.
    Sallan SE; Hitchcock-Bryan S; Gelber R; Cassady JR; Frei E; Nathan DG
    Cancer Res; 1983 Nov; 43(11):5601-7. PubMed ID: 6352020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
    Chessells JM; Durrant J; Hardy RM; Richards S
    J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone.
    Gingrich RD; Armitage JO; Burns CP
    Cancer Treat Rep; 1978 Sep; 62(9):1389-91. PubMed ID: 356988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
    Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
    Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
    Clavell LA; Gelber RD; Cohen HJ; Hitchcock-Bryan S; Cassady JR; Tarbell NJ; Blattner SR; Tantravahi R; Leavitt P; Sallan SE
    N Engl J Med; 1986 Sep; 315(11):657-63. PubMed ID: 2943992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of acute lymphoblastic leukemia therapy in childhood with a modified BFM protocol in a multicenter study in the German Democratic Republic.
    Zintl F; Plenert W; Malke H
    Haematol Blood Transfus; 1987; 30():471-9. PubMed ID: 3305215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult acute lymphoblastic leukemia: results of an aggressive regimen in India.
    Raje N; Pai S; Vaidya S; Gopal R; Parikh P; Saikia T; Pai V; Nadkarni K; Advani IM
    Leuk Lymphoma; 1994 Jul; 14(3-4):285-90. PubMed ID: 7950917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.